Scientific article

Nephrotic Syndrome in Small Cell Lung Cancer and Induction of C-Mip in Podocytes

Published inAmerican journal of kidney diseases, vol. 69, no. 3, p. 477-480
Publication date2017

Paraneoplastic nephrotic syndrome is often a complication in patients with cancer, and various histologic lesions have been described in the kidney. We report the case of a 76-year-old woman who presented with a podocytopathy that was found to be associated with a small cell lung carcinoma (SCLC). One cycle of carboplatin-etoposide combination therapy led to resolution of nephrotic syndrome and remission of the lung carcinoma. C-Maf-inducing protein (C-Mip) was overexpressed in both podocytes and cancer cells, but was not found in control kidney and lung tissue samples. C-Mip also was absent in SCLC cells from 30 patients without nephrotic syndrome. Exposing cultured podocytes to a sample of our patient's serum that was collected prior to chemotherapy led to disorganization of the podocyte cytoskeleton and induction of C-Mip expression, which was not observed with control serum or our patient's serum sampled after chemotherapy. These observations suggest that C-Mip may play an important role in SCLC-related podocytopathy and that a circulating factor likely induces its expression in the kidney.

Citation (ISO format)
BOUATOU, Yassine et al. Nephrotic Syndrome in Small Cell Lung Cancer and Induction of C-Mip in Podocytes. In: American journal of kidney diseases, 2017, vol. 69, n° 3, p. 477–480. doi: 10.1053/j.ajkd.2016.09.026
Main files (1)
Article (Published version)
ISSN of the journal0272-6386

Technical informations

Creation02/02/2017 1:58:00 PM
First validation02/02/2017 1:58:00 PM
Update time03/15/2023 1:40:23 AM
Status update03/15/2023 1:40:23 AM
Last indexation01/16/2024 11:55:43 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack